Surmodics Reports Second Quarter Fiscal 2017 Results, Updates Fiscal 2017 Financial Guidance

Go back to Surmodics Reports Second Quarter Fiscal 2017 Results, Updates Fiscal 2017 Financial Guidance

SurModics (SRDX) Misses Q2 EPS by 2c; Narrows Outlook

April 27, 2017 7:39 AM EDT

SurModics (NASDAQ: SRDX) reported Q2 EPS of $0.05, $0.02 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $17.5 million versus the consensus estimate of $16.23 million.

Total Revenue of $17.5 Million, up 5% year over year; Medical Device revenueincreases 10%EPS of $0.04, Non-GAAP EPS of $0.05Narrows financial outlook for... More